title: Comment on An Open Trial of Lurasidone as an Acute and Maintenance Adjunctive Treatment for Outpatients With Treatment-Resistant Bipolar Disorder.
authors: Shodair Children's Hospital, Helena, MT ian.mcgrane@umontana.edu Faculty of Pharmacy Ljubljana University of Ljubljana and Ormoz's Psychiatric Hospital Ormoz, Slovenia, European Union Ormoz's Psychiatric Hospital, Ormoz, Slovenia, European Union.
authors: Ian Ross
authors: IR
authors: McGrane
authors: Matej
authors: M
authors: Stuhec
mesh_terms: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D001714:Bipolar Disorder; D006801:Humans; D000069056:Lurasidone Hydrochloride; D010045:Outpatients; D016896:Treatment Outcome
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D000069056:Lurasidone Hydrochloride